PDUFA VI Might Adjust Establishment Fees; FDA Aims For Simplification
This article was originally published in The Tan Sheet
User fees would need significant restructuring to make up revenue if establishment fees are eliminated, or even just changed, as part of reauthorization. As part of FDA-industry negotiations, several small working groups are expected to be created to deal with specific issues.
You may also be interested in...
Fee structure changes and process enhancements floated during opening session between industry and agency.
Industry official sees potential for some streamlining in user fee program, but adding to breakthrough and patient-centered activities seems most likely.
Acting Commissioner Ostroff wonders if all aspects of user fee program are delivering maximum added value.